Figure 3. PsA phase 3 clinical trials: short-term ACR 20 responses (data from different trials are not directly comparable)

Figure 3. PsA phase 3 clinical trials: short-term ACR 20 responses (data from different trials are not directly comparable)

Figure 3. PsA phase 3 clinical trials: short-term ACR 20 responses (data from different trials are not directly comparable)

Figure 3. PsA phase 3 clinical trials: short-term ACR 20 responses (data from different trials are not directly comparable)